Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal

benzinga.com/m-a/25/10/48427774/avidity-shareholders-win-big-as-novartis-moves-fast-on-12-billion-deal

Avidity Biosciences, Inc. (NASDAQ:RNA) shares are rocketing premarket on Monday. On Sunday, the company agreed to merge with Novartis AG (NYSE:NVS) in a deal valued at $12 billion on a fully diluted basis.
Transaction Details
As per the deal, Avidity shareholders will receive $72.00 per…

This story appeared on benzinga.com, 2025-10-27 10:11:40.
The Entire Business World on a Single Page. Free to Use →